Skip to content

Clinical trials

Observational Lung Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20091
20101
20111
20131
20142
20162
20183
20193
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Terminated2
Withdrawn2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
CENTOGENE GmbH Rostock2
University of Giessen2
Universitätsmedizin Mannheim2
Aeris Therapeutics1
Broncus Medical Inc1
German Cancer Research Center1
Heidelberg University1
Johannes Gutenberg University Mainz1
Klaus Kenn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases19
Pulmonary Disease, Chronic Obstructive6
Heart Diseases3
Respiratory Tract Diseases3
Cystic Fibrosis2
Emphysema2
Lung Diseases, Interstitial2
Lung Diseases, Obstructive2
Macroglossia2
Sleep Apnea, Obstructive2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.